The pharmaceutical industry seems to be continually at battle for consumer trust, having to combat an onslaught of legislative and legal battles while doing a marketing dance around “the elephant in the room” of fair balance regulations. Sales have slowed and ad spend is down, with the economy pinching demand as customers lose insurance and/or cut back spending on medications. This report delves into the issues surrounding the interactions between consumers and the pharmaceutical industry including topics such as:
- The importance of transparency and creating deeper connections
- How health care reform stands to impact access to medication
- What demographics are most essential and who is falling between the cracks
- How to cope with a unique advertising landscape for marketing success
- Details of the competitive landscape and why consumers opt out of pharmaceuticals
